| Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... The Lancet 397 (10269), 99-111, 2021 | 5299 | 2021 |
| Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial PM Folegatti, KJ Ewer, PK Aley, B Angus, S Becker, ... The Lancet 396 (10249), 467-478, 2020 | 2766 | 2020 |
| Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial MN Ramasamy, AM Minassian, KJ Ewer, AL Flaxman, PM Folegatti, ... The Lancet 396 (10267), 1979-1993, 2020 | 1663 | 2020 |
| Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four … M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... The Lancet 397 (10277), 881-891, 2021 | 1333 | 2021 |
| Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre … APS Munro, L Janani, V Cornelius, PK Aley, G Babbage, D Baxter, M Bula, ... The Lancet 398 (10318), 2258-2276, 2021 | 665 | 2021 |
| Stratum corneum lipids, skin barrier function and filaggrin mutations in patients with atopic eczema JM Jungersted, H Scheer, M Mempel, H Baurecht, L Cifuentes, JK Høgh, ... Allergy 65 (7), 911-918, 2010 | 417 | 2010 |
| Proof-of-concept clinical trial of etokimab shows a key role for IL-33 in atopic dermatitis pathogenesis YL Chen, D Gutowska-Owsiak, CS Hardman, M Westmoreland, ... Science translational medicine 11 (515), eaax2945, 2019 | 208 | 2019 |
| Identification, recombinant expression, and characterization of the 100 kDa high molecular weight Hymenoptera venom allergens Api m 5 and Ves v 3 S Blank, H Seismann, B Bockisch, I Braren, L Cifuentes, M McIntyre, ... The Journal of Immunology 184 (9), 5403-5413, 2010 | 156 | 2010 |
| Api m 10, a genuine A. mellifera venom allergen, is clinically relevant but underrepresented in therapeutic extracts S Blank, H Seismann, Y Michel, M McIntyre, L Cifuentes, I Braren, ... Allergy 66 (10), 1322-1329, 2011 | 150 | 2011 |
| Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer … S Toback, E Galiza, C Cosgrove, J Galloway, AL Goodman, PA Swift, ... The Lancet Respiratory Medicine 10 (2), 167-179, 2022 | 135 | 2022 |
| Dissecting cross-reactivity in hymenoptera venom allergy by circumvention of α-1, 3-core fucosylation H Seismann, S Blank, I Braren, K Greunke, L Cifuentes, T Grunwald, ... Molecular immunology 47 (4), 799-808, 2010 | 132 | 2010 |
| An integrated epigenetic and transcriptomic analysis reveals distinct tissue-specific patterns of DNA methylation associated with atopic dermatitis E Rodriguez, H Baurecht, AF Wahn, A Kretschmer, M Hotze, S Zeilinger, ... Journal of Investigative Dermatology 134 (7), 1873-1883, 2014 | 131 | 2014 |
| IL-22 suppresses IFN-γ–mediated lung inflammation in asthmatic patients D Pennino, PK Bhavsar, R Effner, S Avitabile, P Venn, M Quaranta, ... Journal of Allergy and Clinical Immunology 131 (2), 562-570, 2013 | 109 | 2013 |
| IL-22 suppresses IFN-γ–mediated lung inflammation in asthmatic patients D Pennino, PK Bhavsar, R Effner, S Avitabile, P Venn, M Quaranta, ... Journal of Allergy and Clinical Immunology 131 (2), 562-570, 2013 | 109 | 2013 |
| Effect of acupuncture on allergen-induced basophil activation in patients with atopic eczema: a pilot trial F Pfab, GI Athanasiadis, J Huss-Marp, J Fuqin, B Heuser, L Cifuentes, ... The Journal of Alternative and Complementary Medicine 17 (4), 309-314, 2011 | 94 | 2011 |
| Recombinant phospholipase A1 (Ves v 1) from yellow jacket venom for improved diagnosis of hymenoptera venom hypersensitivity H Seismann, S Blank, L Cifuentes, I Braren, R Bredehorst, T Grunwald, ... Clinical and Molecular Allergy 8, 1-8, 2010 | 73 | 2010 |
| Pollen derived low molecular compounds enhance the human allergen specific immune response in vivo S Gilles‐Stein, I Beck, A Chaker, M Bas, M McIntyre, L Cifuentes, ... Clinical & Experimental Allergy 46 (10), 1355-1365, 2016 | 57 | 2016 |
| Basophil activation test using recombinant allergens: highly specific diagnostic method complementing routine tests in wasp venom allergy L Balzer, D Pennino, S Blank, H Seismann, U Darsow, M Schnedler, ... PLoS One 9 (10), e108619, 2014 | 50 | 2014 |
| Identification of Hymenoptera venom–allergic patients with negative specific IgE to venom extract by using recombinant allergens L Cifuentes, S Vosseler, S Blank, H Seismann, D Pennino, U Darsow, ... Journal of Allergy and Clinical Immunology 133 (3), 909-910, 2014 | 50 | 2014 |
| Early life I g E responses in children living in the tropics: A prospective analysis J Zakzuk, N Acevedo, L Cifuentes, A Bornacelly, J Sánchez, V Ahumada, ... Pediatric Allergy and Immunology 24 (8), 788-797, 2013 | 49 | 2013 |
